HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus

Modern Pathology

Volumn 22, Issue 8, 2009, Pages 1075-1082

  Simões, Renata T ^a   Gonçalves, Maria Alice G ^a   Castelli, Erick C ^a   Júnior, Celso M ^a   Bettini, Jussara S R ^a   L Discorde, Magali ^b   Duarte, Geraldo ^a   Quintana, Silvana M ^a   Simões, Aguinaldo L ^a   Moreau, Philippe ^b   Carosella, Edgardo D ^b   Soares, Edson G ^a   Donadi, Eduardo A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

Author keywords

Cervical cancer; HLA G gene polymorphism; HLA G haplotypes; HPV; Human papillomavirus infection

Indexed keywords

HLA G ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; EXON; FEMALE; GENE DELETION; GENE INSERTION; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

EID: 68249132444     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2009.67     Document Type: Article

References (47)

1. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-527.
2. O'Brien PM, Saveria Campo M. Evasion of host immunity directed by papillomavirus-encoded proteins. Virus Res 2002;88:103-117.
3. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-1278.
4. Carosella ED, Favier B, Rouas-Freiss N, et al. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 2008;111:4862-4870.
5. Georgopoulos NT, Proffitt JL, Blair GE. Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins. Oncogene 2000;19:4930-4935.
6. Borrego F, Kabat J, Kim DK, et al. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Mol Immunol 2002;38:637-660.
7. Carosella ED, Moreau P, Le Maoult J, et al. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol 2003;81:199-252.
8. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 1997;94:11520-11525.
9. Fujii T, Ishitani A, Geraghty DE. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol 1994;153: 5516-5524.
10. Crisa L, McMaster MT, Ishii JK, et al. Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J Exp Med 1997;186:289-298.
11. Goncalves MA, Le Discorde M, Simoes RT, et al. Classical and non-classical HLA molecules and p16(INK4a) expression in precursors lesions and invasive cervical cancer. Eur J Obstet Gynecol Reprod Biol 2008;141:70-74.
12. Rouas-Freiss N, Moreau P, Ferrone S, et al. HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism? Cancer Res 2005;65:10139-10144.
13. Lafon M, Prehaud C, Megret F, et al. Modulation of HLA-G expression in human neural cells after neurotropic viral infections. J Virol 2005;79:15226-15237.
14. Lozano JM, Gonzalez R, Kindelan JM, et al. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 2002;16:347-351.
15. Onno M, Pangault C, Le Friec G, et al. Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 2000;164:6426-6434.
16. LeMaoult J, Krawice-Radanne I, Dausset J, et al. HLA G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci USA 2004;101:7064-7069.
17. Fournel S, Aguerre-Girr M, Huc X, et al. Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 2000;164:6100-6104.
18. Anthony Nan Research Institute. Full List of HLA Class I alleles. http://hla.alleles.org/class1.html 2009, Accessed: 7 March 2007.
19. Rebmann V, van der Ven K, Passler M, et al. Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens 2001;57:15-21.
20. Hviid TV, Hylenius S, Rorbye C, et al. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003;55:63-79.
21. Hiby SE, King A, Sharkey A, et al. Molecular studies of trophoblast HLA-G: polymorphism, isoforms, imprinting and expression in preimplantation embryo. Tissue Antigens 1999;53:1-13.
22. Rousseau P, Le Discorde M, Mouillot G, et al. The 14 bp deletion-insertion polymorphism in the 3′ UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 2003;64:1005-1010.
23. Gazit E, Sherf M, Balbin E, et al. HLA-G expression is induced in Epstein-Barr virus-transformed B-cell lines by culture conditions. Hum Immunol 2007;68: 463-468.
24. Megret F, Prehaud C, Lafage M, et al. Modulation of HLA-G and HLA-E expression in human neuronal cells after rabies virus or herpes virus simplex type 1 infections. Hum Immunol 2007;68:294-302.
25. Pangault C, Le Tulzo Y, Minjolle S, et al. HLA-G expression in Guillain-Barre syndrome is associated with primary infection with cytomegalovirus. Viral immunology 2004;17:123-125.
26. Higuchi R. Simple and rapid preparation of samples for PCR In: Erlich HA (ed). PCR Technology: Principles and Applications for DNA Amplification. Stockton Press: New York, 1989, pp 31-38.
27. Manos MM, Ting Y, Wright DK, et al. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses In: Furth M, Greaves M (eds). Molecular Diagnostics of Human Cancer: Cancer Cells Vol. 7, Cold Spring Harbor Laboratory: New York, 1989, pp 209-214.
28. Freitas TP, Carmo BB, Paula FD, et al. Molecular detection of HPV 16 and 18 in cervical samples of patients from Belo Horizonte, Minas Gerais, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo 2007;49:297-301.
29. Pereira CR, Rosa ML, Vasconcelos GA, et al. Human papillomavirus prevalence and predictors for cervical cancer among high-risk women from Rio de Janeiro, Brazil. Int J Gynecol Cancer 2007;17:651-660.
30. Zereu M, Zettler CG, Cambruzzi E, Zelmanowicz A. Herpes simplex virus type 2 and Chlamydia trachomatis in adenocarcinoma of the uterine cervix. Gynecol Oncol 2007;105:172-175.
31. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide (see comments). J Pathol 1999;189:12-19.
32. Morales P, Corell A, Martinez-Laso J, et al. Three new HLA-G alleles and their linkage disequilibria with HLA-A. Immunogenetics 1993;38:323-331.
33. Sanguinetti CJ, Dias Neto E, Simpson AJ. Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques 1994;17:914-921.
34. Castelli EC, Mendes-Junior CT, Donadi EA. HLA-G alleles and HLA-G 14 bp polymorphisms in a Brazilian population. Tissue Antigens 2007;70:62-68.
35. Bermingham J, Jenkins D, McCarthy T, et al. Genetic analysis of insulin-like growth factor II and HLA-G in pre-eclampsia. Biochem Soc Trans 2000; 28:215-219.
36. Raymond M, Rousset F. GENEPOP on the Web (Version 3.4). http://wbiomed.curtin.edu.au/genepop/2.0 edn, Vol. 83, J Heredity 2004, pp 248-249.
37. GraphPad. GraphPad InStat Version 3.00 for Windows 95 3.01 edn GraphPad Software Inc.: San Diego, CA, USA, 1998.
38. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995;12:921-927.
39. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-989.
40. Carosella ED, Moreau P, Lemaoult J, et al. HLA-G: from biology to clinical benefits. Trends Immunol 2008;29: 125-132.
41. Yoon BS, Kim YT, Kim JW, et al. Expression of human leukocyte antigen-G and its correlation with interleukin-10 expression in cervical carcinoma. Int J Gynaecol Obstet 2007;98:48-53.
42. Zhou JH, Ye F, Chen HZ, et al. Altered expression of cellular membrane molecules of HLA-DR, HLA-G and CD99 in cervical intraepithelial neoplasias and invasive squamous cell carcinoma. Life Sci 2006;78: 2643-2649.
43. Polakova K, Russ G. Expression of the non-classical HLA-G antigen in tumor cell lines is extremely restricted. Neoplasma 2000;47:342-348.
44. Ades S, Koushik A, Duarte-Franco E, et al. Selected class I and class II HLA alleles and haplotypes and risk of high-grade cervical intraepithelial neoplasia. Int J Cancer 2008;122:2820-2826.
45. Chan DP, Cheung TH, Tam AO, et al. Risk association between human leukocyte antigen-A allele and high-risk human papillomavirus infection for cervical neoplasia in Chinese women. J Infect Dis 2005; 192:1749-1756.
46. de Araujo Souza PS, Maciag PC, Ribeiro KB, et al. Interaction between polymorphisms of the human leukocyte antigen and HPV-16 variants on the risk of invasive cervical cancer. BMC Cancer 2008;8:246.
47. Eiguchi K, Tatti S, Alonio LV, et al. Association of DRB1 and DQB1 HLA class II polymorphisms in high-grade and neoplastic cervical lesions of women from Argentina. J Low Genit Tract Dis 2008;12:262-268.